Total femur prosthesis in oncological and not oncological series. Survival and failures

Francesco Muratori; Nicola Mondanelli; Xhulio Prifti; Guido Scoccianti; Giuliana Roselli; Filippo Frenos; Rodolfo Capanna; Domenico Andrea Campanacci

doi:10.1016/j.jor.2019.11.009

Total femur prosthesis in oncological and not oncological series. Survival and failures

J Orthop. 2019 Nov 12:17:215-220. doi: 10.1016/j.jor.2019.11.009. eCollection 2020 Jan-Feb.

Authors

Francesco Muratori¹, Nicola Mondanelli², Xhulio Prifti¹, Guido Scoccianti¹, Giuliana Roselli³, Filippo Frenos¹, Rodolfo Capanna⁴, Domenico Andrea Campanacci¹

Affiliations

¹ Divisione di Ortopedia Oncologica e Ricostruttiva, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy.
² Divisione Ortopedia e Traumatologia, Azienda Ospedaliera Universitaria, Siena, Italy.
³ Istituto di Radiologia, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy.
⁴ Clinica Ortopedica Universitaria, Pisa, Italy.

Abstract

Total femur prosthesis (TFP) can be used in both oncological and prosthetic revision surgery. A retrospective analysis of 32 patients receiving a TFP at a single Center between 2002 and 2018 was performed. The average follow-up was 60 months. Revision implant free survival (RIFS) of the implants was 87% at 5 and 10 years and 72% at 15 years. Overall implant survival (OIS) of the prosthesis was 90% at 5, 10 and 15 years. Complications observed: two soft tissue failures, two infection failure and one tumor progression failure.

Keywords: Dislocation; Failure; Infectious; Total femur prosthesis; Tumor.